Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances

Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances

Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program

Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program

Recce Pharmaceuticals teams with leading Indonesian biomed company for anti-infective push

Recce Pharmaceuticals teams with leading Indonesian biomed company for anti-infective push

Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong

Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong

Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong

Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong

Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327

Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327

4 Biotech Executives Share Strategies Behind Successful Fund Raises

4 Biotech Executives Share Strategies Behind Successful Fund Raises

Recce Pharmaceuticals higher on positive efficacy data in Murdoch Children’s Research Institute UTI study

Recce Pharmaceuticals higher on positive efficacy data in Murdoch Children’s Research Institute UTI study

Recce Pharmaceuticals — Landmark commitment helps fund R&D costs

Recce Pharmaceuticals — Landmark commitment helps fund R&D costs

Recce secures Australia’s largest-ever $11m Advanced Overseas R&D Finding

Recce secures Australia’s largest-ever $11m Advanced Overseas R&D Finding